CSIMarket
 
Clearmind Medicine Inc   (CMND)
Other Ticker:  
 
    Sector  Technology    Industry Software & Programming
   Industry Software & Programming
   Sector  Technology
 


As one of many companies, the CMND disclosed also the fourth quarter of 2022 results

Clearmind Medicine Inc announced fourth quarter of 2022 operating shortfall of $-6.535955514 millions

Published 2023-02-07T10:50:27+00:00
Goran Soko / CSIMarket.com Contributer

podium_By_James38_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons After the large companies in the Software & Programming industry, a number of smaller companies are coming in with the numbers. CMND said it has announced operating shortfall of $-6.535955514 millions, for the fourth quarter of 2022.

The operating shortfall has deteriorated from $-0.008356 millions, from the fourth quarter of 2017. But more crucially, the analysts are speculating, when the Software & Programming company's could begin to cite the revenue.


The CFO is pursuing various corporate policies, consecutively to ensure product line. Meanwhile the net loss, that the company has encountered over the developing cycle, has extended to $-7.209 millions, from $-0.008 millions, from the fourth quarter of 2017.


Clearmind Medicine Inc is expected to report next financial earnings on February 02, 2024.


Clearmind Medicine Inc Suppliers

Clearmind Medicine Inc Revenue growth Rates

    Recently Reported Results
Radiant Logistics Inc

EPS Drops due to Weak Sales at in the second quarter of 2023

In the second quarter of 2023 financial report RLGT reported soft top and bottom-line, where income per share dropped by -28.57 % and revenue by -16.423 % year on year. Revenue were to $278.12 millions in proportion to $332.77 millions eps at $0.10 in proportion to $0.14 in second quarter of 2022.

Radiant Logistics Inc stock quotes, charts, profile

Radiant Logistics Inc Income Statement, Balance sheets, Cash Flow Statement

housing-58496_960_720 Housing Starts


New housing units authorized by region

New housing units started by region

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Cytomx Therapeutics Inc

Shifting our appreciation to the fourth quarter of 2022 earnings season CTMX lost money at $-0.42 per share, relative to the recent numbers of $-0.91 per share a year prior reporting season, In the preceding reporting season CTMX realized $-0.35 per share.

Cytomx Therapeutics Inc Customers

Cytomx Therapeutics Inc Revenue elevation Rates

Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Acer Therapeutics Inc

For the financial fourth quarter of 2022 company increased a loss per share of $-0.54 per share compare to $-0.30 a year ago and increased loss from $-0.31 per share from the preceding financial reporting period.

Revenues remained unaffected to $0.00 millions from $0.36 millions in the same financial reporting period a year ago and sequentially Revenue Tumbled from $0.00 millions.

Acer Therapeutics Inc Customers

Acer Therapeutics Inc Income Statement, Balance sheets, Cash Flow Statement

Pennsylvania Real Estate Investment Trust

Soft Top-line at the company over the financial period closing Dec 31 2022

For the fourth quarter of 2022 earnings season company Losses have extended of $-7.81 per share compare to $-0.43 a year before and Income per Share improved from $-14.52 per share from the previous reporting period.

Revenues sunk by -5.307 % to $80.65 millions from $85.17 millions in the comparable reporting period a year before and sequentially Revenues advanced by 10.767 % from $72.81 millions.

Pennsylvania Real Estate Investment Trust stock quotes, charts, profile

Pennsylvania Real Estate Investment Trust rise Rates, Profitability, PE

Kitchen_stuff_By_Smoth_007_from_Christchurch_New_Zealand__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Durable Goods Orders

Durable Goods orders rebounded in October

U.S. Durable Goods orders grew again after dipping in the last month, but orders excluding volatile transportation sector decreased. That category excludes defense and transportation and gives a better indication of longer-term trends in the private sector.

dollar-1175048_960_720 Gross Domestic Product

Gross Domestic Product grows 2.6 % in the third-quarter

U.S. economy grows to an annual rate of 2.6 %, as the U.S. trade balance improves.

factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

U.S. production output continued to fell


Autosample_takes_a_By_Hey_Paul_(originally_posted_to_Flickr_as_image4)_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Commons Terns Pharmaceuticals Inc

For the financial fourth quarter of 2022 company decreased a loss per share of $-0.23 per share compare to $-0.56 a year prior and EPS improved from $-0.44 per share from the previous reporting season.

Revenues remained unscathed to $0.00 millions from $1.00 millions in the same reporting season a year prior and sequentially Revenues advanced from $0.00 millions.

Terns Pharmaceuticals Inc stock quotes, charts, profile

Terns Pharmaceuticals Inc Income Statement, Balance sheets, Cash Flow Statement

Aerial_open_mine_by_Steve_Jurvetson__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Gold Royalty Corp

For the most recent fiscal period company lost money of $-0.14 per share compare to $-0.14 a year before and from $0.00 per share from the previous reporting season.

Revenues remained unchanged by 0 % to $3.94 millions from $3.94 millions in the same reporting season a year before and sequentially Revenues advanced from $0.00 millions.

Gold Royalty Corp stock quotes, charts, profile

Gold Royalty Corp elevation Rates, Profitability, PE

BuySell_pd.jpg P10 Inc

Directing the thoughts to the fiscal three months ending December 31 2022 P10 Inc profits turned positive at $0.03 per share, relative to the earnings of $-3.47 per share a year ago reporting period, In the prior reporting period the Investment Services company realized $0.05 per share.

P10 Inc stock quotes, charts, profile

P10 Inc Suppliers

LLPX_2235_User.Morven__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Freightcar America Inc

Compelling period by RAIL all along the most recent fiscal period

For the April to June 30 2022 interval RAIL had turn a round to income by presenting earnings per share of $0.58 per share compare to $-0.13 a year ago and EPS turned positive from $-1.11 per share from the preceding reporting season.

Revenues inched up strongly by 52.021 % to $56.79 millions from $37.35 millions in the same reporting season a year ago and sequentially Revenue Tumbled by -39.094 % from $93.24 millions.

Freightcar America Inc Competitors, Market Share

Freightcar America Inc rise Rates, Profitability, PE

Shopping_Malll_Antwerpen_By_FaceMePLS_from_The_Hague_[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Abercrombie And Fitch Co

Significant Income per Share Deterioration at the Abercrombie And Fitch Co over the fourth quarter of 2022 earnings season

ANF reported declining eps on increasing revenue in the financial three months ending January 28 2023, where Revenue grew by 3.312 % to $1.20 billions in comparison to $1.16 billions on a year-over-year basis, while net profit per share dropped by -29.1 % to $0.78 per share, income per share was $1.10 in the same three months a year before.

Abercrombie And Fitch Co Customers

Abercrombie And Fitch Co elevation Rates, Profitability, PE

Spectral Capital Corporation

In the fiscal three months ending December 31 2022 company reached 0 at $0.00 per share, opposite of $0.00 per share a year ago quarter, In the previous quarter Spectral Capital Corporation realized $0.00 per share.

Spectral Capital Corporation Competitors, Market Share

Spectral Capital Corporation Revenue elevation Rates



Other CMND's Earnings Reports

Clearmind Medicine Inc reported third quarter 2022 earnings

Clearmind Medicine Inc reported second quarter 2022 earnings

Clearmind Medicine Inc reported first quarter 2022 earnings

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SRE's Profile

Stock Price

SRE's Financials

Business Description

Fundamentals

Charts & Quotes

SRE's News

Suppliers

SRE's Competitors

Customers & Markets

Economic Indicators

SRE's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071